rs104894427
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000266126.10(EIF2B2):c.547C>T(p.Arg183Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000242 in 1,612,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
EIF2B2
ENST00000266126.10 stop_gained
ENST00000266126.10 stop_gained
Scores
2
4
1
Clinical Significance
Conservation
PhyloP100: 3.88
Genes affected
EIF2B2 (HGNC:3258): (eukaryotic translation initiation factor 2B subunit beta) This gene encodes the beta subunit of eukaryotic initiation factor-2B (EIF2B). EIF2B is involved in protein synthesis and exchanges GDP and GTP for its activation and deactivation. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-75004850-C-T is Pathogenic according to our data. Variant chr14-75004850-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 4338.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2B2 | NM_014239.4 | c.547C>T | p.Arg183Ter | stop_gained | 4/8 | ENST00000266126.10 | NP_055054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2B2 | ENST00000266126.10 | c.547C>T | p.Arg183Ter | stop_gained | 4/8 | 1 | NM_014239.4 | ENSP00000266126 | P1 | |
ENST00000554430.1 | n.358G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151164Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
2
AN:
151164
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 251026Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135776
GnomAD3 exomes
AF:
AC:
3
AN:
251026
Hom.:
AF XY:
AC XY:
0
AN XY:
135776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461602Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727084
GnomAD4 exome
AF:
AC:
37
AN:
1461602
Hom.:
Cov.:
33
AF XY:
AC XY:
12
AN XY:
727084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151164Hom.: 0 Cov.: 28 AF XY: 0.0000271 AC XY: 2AN XY: 73780
GnomAD4 genome
AF:
AC:
2
AN:
151164
Hom.:
Cov.:
28
AF XY:
AC XY:
2
AN XY:
73780
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 4338). This premature translational stop signal has been observed in individual(s) with clinical features of leukoencephalopathy with vanishing white matter (PMID: 12707859). This variant is present in population databases (rs104894427, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg183*) in the EIF2B2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2B2 are known to be pathogenic (PMID: 11704758, 12707859). - |
Leukoencephalopathy with vanishing white matter 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2003 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at